title: Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.
abstract: BACKGROUND
  The prognostic impact of reduced glomerular filtration rate (GFR) in chronic heart failure (CHF) is increasingly recognised, but little is known about tubular damage in these patients.
  
  
  OBJECTIVE
  To investigate the prevalence of tubular damage, and its association with GFR, and prognosis in patients with CHF.
  
  
  RESULTS
  In 90 patients with CHF, GFR and effective renal plasma flow (ERPF) were measured ([(125)I]iothalamate and [(131)I]hippuran clearances). The tubular markers neutrophil gelatinase-associated lipocalin (NGAL), N-acetyl-beta-D-glucosaminidase (NAG) and kidney injury molecule 1 (KIM-1) as well as urinary albumin excretion were determined in 24 h urine collections. Mean GFR was 78+/-26 ml/min/1.73 m(2). Urinary NGAL (175 (70-346) microg/g creatinine (gCr)), NAG (12 (6-17) U/gCr) and KIM-1 (277 (188-537) ng/gCr) levels were increased compared with 20 healthy controls (all p<0.001). Urinary NAG, but not NGAL or KIM-1 correlated with GFR (r=-0.34, p=0.001) and ERPF (r=-0.29, p=0.006). Both NAG (r=0.21, p=0.048) and KIM-1 (r=0.23, p=0.033) correlated with plasma N-terminal pro-brain natriuretic peptide levels. Both urinary KIM-1 (HR=1.15 (95% CI 1.02 to 1.30) per 100 ng/gCr increase, p=0.025) and NAG (HR=1.42 (95% CI 1.02 to 1.94) per 5 U/gCr increase, p=0.039), were associated with an increased risk of death or heart failure hospitalisations, independent of GFR.
  
  
  CONCLUSIONS
  Tubular damage, as indicated by increased urinary concentrations of NGAL, NAG and KIM-1 is common in patients with CHF and mildly reduced GFR. Both urinary KIM-1 and NAG showed prognostic information additional to GFR. These findings suggest an important role for tubular damage and tubular markers in cardiorenal interaction in heart failure.
authors.affiliation: Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
authors.forename: Kevin
authors.initials: K
authors.lastname: Damman
authors.forename: Dirk J
authors.initials: DJ
authors.lastname: Van Veldhuisen
authors.forename: Gerjan
authors.initials: G
authors.lastname: Navis
authors.forename: Vishal S
authors.initials: VS
authors.lastname: Vaidya
authors.forename: Tom D J
authors.initials: TD
authors.lastname: Smilde
authors.forename: B Daan
authors.initials: BD
authors.lastname: Westenbrink
authors.forename: Joseph V
authors.initials: JV
authors.lastname: Bonventre
authors.forename: Adriaan A
authors.initials: AA
authors.lastname: Voors
authors.forename: Hans L
authors.initials: HL
authors.lastname: Hillege
mesh_terms: D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood / Q000652:urine; D002908:Chronic Disease; D004812:Epidemiologic Methods; D005260:Female; D005919:Glomerular Filtration Rate / Q000502:physiology; D054143:Heart Failure, Systolic / Q000150:complications* / Q000401:mortality / Q000503:physiopathology; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology* / Q000401:mortality / Q000503:physiopathology; D007684:Kidney Tubules / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012079:Renal Circulation / Q000502:physiology; D055815:Young Adult
chemical_list: D015415:Biomarkers